<< Back to the main event page
Life-course Immunisation for Older Adults in Asia: a Health Economics Case
13. How will submissions be evaluated?
Each entry should be focused on sharing ideas demonstrating the value of life-course immunisation, i.e., vaccination for the elderly population, at the national level of a Southeast Asian country of choice. The story to be told within a submission should include the points listed under Question 7.
14. What are the judging criteria?
The evaluation of each entry will be focused on sharing ideas demonstrating the value of life-course immunisation, i.e., vaccination for the elderly population, at the national level a Southeast Asian country of choice. The evaluation will be based on the following qualities:
- Clear qualitative definition of a focus problem and the quantified size of the problem
- Proof/evidence of the proposed solution (e.g., ROI) (Feasibility)
- Scalability of the proposed solution
- Qualitative impact of the proposed solution (Impact)
- Overall presentation of results, including creativity therein
15. Who will judge the entries?
An independent panel of regional healthcare experts from public health, policy and academia will review each entry and vote on one entry as the best submission, per category. The decision of the judges is final, and no appeals will be entertained.
16. How many best submissions will be selected?
One submission each from the Rising Stars category and the Working Professionals category will be selected as the Best submission.
17. When and how will the best submissions entries be notified?
The applicant with the best submissions will be notified by the end of November via email. Those who were not successful in their entry will likewise be notified.
A formal announcement of the best submissions will be made during a webinar organised by SEADS and EU-ABC, supported by Sanofi. Please refer to Question 18.